StockData
Lexaria Bioscience Corp. logo

Lexaria Bioscience Corp. (LEXX) stock

LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.18−0.23 (-5.22%)

Close on Nov 17, 2026Market cap $103.61MP/E –Yield –

Lexaria Bioscience cash

Cash and short-term investments held at the end of each period.

Lexaria Bioscience's cash was $3.64M at May 31, 2026. For fiscal 2025 it was $1.95M, down 70.3% from the year before. Over ten years it grew 22.3% a year on average. The highest annual figure on record is $11.75M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Aug 31, 2025$1.95M-70.3%
FY2024Aug 31, 2024$6.56M+343.6%
FY2023Aug 31, 2023$1.48M-76.0%
FY2022Aug 31, 2022$6.16M-47.6%
FY2021Aug 31, 2021$11.75M+795.0%
FY2020Aug 31, 2020$1.31M-2.7%
FY2019Aug 31, 2019$1.35M-22.3%
FY2018Aug 31, 2018$1.74M-31.4%
FY2017Aug 31, 2017$2.53M+2612.1%
FY2016Aug 31, 2016$93.41K-64.1%
FY2015Aug 31, 2015$260.08K+296.8%
FY2013Oct 31, 2013$65.54K-63.7%
FY2012Oct 31, 2012$180.51K+478.6%
FY2011Oct 31, 2011$31.20K-50.5%
FY2010Oct 31, 2010$62.99K-80.9%
FY2009Oct 31, 2009$330.17K–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026May 31, 2026$3.64M-21.3%
Q2 FY2026CQ1 2026Feb 28, 2026$5.24M-19.9%
Q1 FY2026CQ4 2025Nov 30, 2025$4.44M-45.3%
Q4 FY2025CQ3 2025Aug 31, 2025$1.95M-70.3%
Q3 FY2025CQ2 2025May 31, 2025$4.63M-45.6%
Q2 FY2025CQ1 2025Feb 28, 2025$6.54M+36.5%
Q1 FY2025CQ4 2024Nov 30, 2024$8.12M+300.6%
Q4 FY2024CQ3 2024Aug 31, 2024$6.56M+343.6%
Q3 FY2024CQ2 2024May 31, 2024$8.51M+147.7%
Q2 FY2024CQ1 2024Feb 29, 2024$4.79M+35.4%
Q1 FY2024CQ4 2023Nov 30, 2023$2.03M-57.8%
Q4 FY2023CQ3 2023Aug 31, 2023$1.48M-76.0%
Q3 FY2023CQ2 2023May 31, 2023$3.43M-53.2%
Q2 FY2023CQ1 2023Feb 28, 2023$3.54M-60.3%
Q1 FY2023CQ4 2022Nov 30, 2022$4.80M-52.8%
Q4 FY2022CQ3 2022Aug 31, 2022$6.16M-47.6%
Q3 FY2022CQ2 2022May 31, 2022$7.34M-13.8%
Q2 FY2022CQ1 2022Feb 28, 2022$8.91M-9.2%
Q1 FY2022CQ4 2021Nov 30, 2021$10.18M+1688.1%
Q4 FY2021CQ3 2021Aug 31, 2021$11.75M+795.0%
Q3 FY2021CQ2 2021May 31, 2021$8.51M+314.6%
Q2 FY2021CQ1 2021Feb 28, 2021$9.82M+1185.7%
Q1 FY2021CQ4 2020Nov 30, 2020$569.07K-58.0%
Q4 FY2020CQ3 2020Aug 31, 2020$1.31M-2.7%
Q3 FY2020CQ2 2020May 31, 2020$2.05M-0.9%
Q2 FY2020CQ1 2020Feb 29, 2020$763.61K-63.1%
Q1 FY2020CQ4 2019Nov 30, 2019$1.36M-50.1%
Q4 FY2019CQ3 2019Aug 31, 2019$1.35M-22.3%
Q3 FY2019CQ2 2019May 31, 2019$2.07M-0.5%
Q2 FY2019CQ1 2019Feb 28, 2019$2.07M-10.8%
Q1 FY2019CQ4 2018Nov 30, 2018$2.72M+22.9%
Q4 FY2018CQ3 2018Aug 31, 2018$1.74M-31.4%
Q3 FY2018CQ2 2018May 31, 2018$2.08M-25.4%
Q2 FY2018CQ1 2018Feb 28, 2018$2.32M+342.6%
Q1 FY2018CQ4 2017Nov 30, 2017$2.21M+1678.5%
Q4 FY2017CQ3 2017Aug 31, 2017$2.53M+2612.1%
Q3 FY2017CQ2 2017May 31, 2017$2.79M–
Q2 FY2017CQ1 2017Feb 28, 2017$523.63K–
Q1 FY2017CQ4 2016Nov 30, 2016$124.25K–
Q4 FY2016CQ3 2016Aug 31, 2016$93.41K–

More Lexaria Bioscience figures

See a number that looks wrong?